400 Jobs Cut in Bloomington Amongst Novo Nordisk Layoffs

400 jobs cut in Bloomington amongst Novo Nordisk layoffs

BLOOMINGTON, Ind. — Around 400 Hoosiers will soon be out of a job after a massive pharmaceutical company announced that its Bloomington site will cut over 20% of its staff. Significant layoffs Novo Nordisk, the company behind Ozempic and Wegovy, confirmed Tuesday that its drug manufacturing site in Bloomington will have a "workforce reduction of [...]

Novo Nordisk to cut 400 jobs at Bloomington facility

Open the article to view the coverage from WRTV

Layoffs at Novo’s Ex-Catalent Site Despite Signs of Turnaround, Continued Investment

As Novo Nordisk cuts 400 jobs at the troubled site, Scholar Rock has seen enough progress that it included the facility in a resubmission for FDA approval.

Novo cuts 400 jobs in Indiana as Scholar Rock refiles drug linked to the factory

Novo Nordisk is laying off roughly 400 staffers at the Bloomington, IN, factory it recently acquired, after manufacturing issues led the FDA to reject drugs from three separate companies that had contracted with the facility. ...

Novo Nordisk cuts 400 jobs at US factory - The Copenhagen Post

Danish pharmaceutical giant Novo Nordisk is cutting approximately 400 positions at its Bloomington facility in Indiana following a “comprehensive restructuring.” Scheduled for early May, the layoffs will leave about 1,400 employees at the site, which produces the weight-loss drug Wegovy. Novo Nordisk acquired the plant through its purchase of Catalent to meet soaring demand for […]